META
Meta Platforms, Inc.
META has the edge over MSGK overall, supported by stronger valuation and stronger modeled upside.
MSGK
Madison Square Garden Sports Corp.
MSGK has slightly lower modeled downside risk, despite its lower overall score.
META Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Healthy |
META's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
MSGK Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Under pressure | |
| Weak |
MSGK's revenue and profitability are currently healthy, but its cash flow and balance sheet are under pressure.
META PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 19x | $624 | — |
| Cheap | 21x | $613 | -1.7% |
| Current | 21x | $624 | — |
| Fair | 27x | $803 | +29% |
| Expensive | 32x | $934 | +50% |
Historical ranges are pointers, not guarantees.
META's PE is in its cheap range at 21x. If earnings grow as analysts expect, today's price would be 19x next year's earnings.
MSGK PE Valuation
MSGK has no meaningful PE right now: it lost money over the past year.
META Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Strong growth | |
| Strongly weakening | |
| Moderate | |
| Low |
Analysts expect earnings and revenue growth for META, but weaker profitability. However, they disagree widely on these estimates.
MSGK Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Stable | |
| Improving | |
| Limited | |
| High |
Analysts expect MSGK's losses to shrink, with revenue holding steady.
META Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $32.16 | +9.7% |
| Q3 2026 | $29.32 | +30% |
| Q2 2026 | $26.54 | -3.7% |
| Q1 2026 | $27.50 | +7.5% |
| Q4 2025 | $23.49 | -1.6% |
| Q3 2025 | $22.58 | +6.5% |
| Q2 2025 | $27.56 | +41% |
| Q1 2025 | $25.58 | +47% |
| Q4 2024 | $23.86 | +60% |
META has the edge over MSGK on earnings, with more consistent year-over-year improvement.
MSGK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $0.24 | +$0.94 |
| Q1 2026 | -$0.71 | -518% |
| Q4 2025 | -$0.53 | -130% |
| Q3 2025 | -$0.75 | -134% |
| Q2 2025 | -$0.70 | -138% |
| Q1 2025 | $0.17 | -77% |
| Q4 2024 | $1.79 | +50% |
| Q3 2024 | $2.20 | +59% |
MSGK has returned to profit: it earned $0.24 per share over the past year, after losing money the year before.
META Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $64.6B | +26% |
| Q2 2026 | $60.8B | +28% |
| Q1 2026 | $56.3B | +33% |
| Q4 2025 | $59.9B | +24% |
| Q3 2025 | $51.2B | +26% |
| Q2 2025 | $47.5B | +22% |
| Q1 2025 | $42.3B | +16% |
| Q4 2024 | $48.4B | +21% |
META has the edge over MSGK on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | -20 points |
| Q2 2026 | 31% | -12 points |
| Q1 2026 | 41% | -0.9 points |
| Q4 2025 | 41% | -7 points |
| Q3 2025 | 40% | -2.7 points |
| Q2 2025 | 43% | +5 points |
| Q1 2025 | 41% | +3.6 points |
| Q4 2024 | 48% | +7.4 points |
META has the edge over MSGK on profitability, with a higher operating margin.
MSGK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $45.5M | +15% |
| Q2 2026 | $278.7M | +37% |
| Q1 2026 | $432.2M | +1.9% |
| Q4 2025 | $403.4M | +13% |
| Q3 2025 | $39.5M | -26% |
| Q2 2025 | $204M | -10% |
| Q1 2025 | $424.2M | -1.3% |
| Q4 2024 | $357.8M | +9.4% |
MSGK's revenue is recovering but still below its 2019 peak: $45M last quarter, up 15% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -56% | +14 points |
| Q2 2026 | 12% | +23 points |
| Q1 2026 | 0.5% | -7.2 points |
| Q4 2025 | 5.5% | +1.8 points |
| Q3 2025 | -70% | -54 points |
| Q2 2025 | -11% | -34 points |
| Q1 2025 | 7.6% | -11 points |
| Q4 2024 | 3.7% | -5.1 points |
MSGK's operating margin was −56% last quarter, up 14 points from the same quarter a year ago.
META Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.2B | -110% |
| Q2 2026 | $1.7B | -81% |
| Q1 2026 | $13.2B | +19% |
| Q4 2025 | $14.8B | +9.3% |
| Q3 2025 | $11.2B | -32% |
| Q2 2025 | $9B | -19% |
| Q1 2025 | $11.1B | -14% |
| Q4 2024 | $13.6B | +16% |
META has the edge over MSGK on cash generation, producing positive trailing cash flow while its opponent burns cash.
MSGK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$146.9M | -$61.6M |
| Q2 2026 | $57.6M | +17% |
| Q1 2026 | $57.4M | +1369% |
| Q4 2025 | $31.6M | -48% |
| Q3 2025 | -$85.3M | -$58.8M |
| Q2 2025 | $49.4M | -54% |
| Q1 2025 | $3.9M | -0.9% |
| Q4 2024 | $61.2M | +84% |
MSGK's free cash flow was −$353,000 over the past year, against $29M the year before.
META Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +7M shares |
| 1 year | 0% | +1M shares |
| 3 years | -2.6% | -68M shares |
| 5 years | -10% | -286M shares |
| Available history | -11% | -303M shares |
META has the edge over MSGK on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | $3.3B |
| Q2 2025 | $10.2B |
| Q1 2025 | $12.8B |
| Q4 2024 | — |
META hasn't bought back shares in the past year.
MSGK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +113K shares |
| 1 year | +0.7% | +216K shares |
| 3 years | +0.2% | +77K shares |
| 5 years | +0.5% | +163K shares |
| Available history | -28% | -12.4M shares |
MSGK has 32M diluted shares, up 0.7% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2020 | $330,000 |
META Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.6x | Very low |
| Q1 2026 | 0.3x | Very low |
| Q4 2025 | 0.2x | Very low |
| Q3 2025 | 0.2x | Very low |
| Q2 2025 | 0.2x | Very low |
| Q1 2025 | 0.0x | Very low |
| Q4 2024 | -0.2x | Net Cash |
META has the edge over MSGK on leverage, with a lower net debt burden relative to earnings.
MSGK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 7.6x | High |
| Q2 2026 | 2.9x | Moderate |
| Q4 2025 | 27.0x | High |
| Q2 2025 | 8.1x | High |
| Q1 2025 | 2.1x | Moderate |
| Q4 2024 | 1.4x | Healthy |
| Q3 2024 | 1.6x | Healthy |
| Q2 2024 | 1.5x | Healthy |
MSGK's net debt is about 7.6 years of its operating earnings (EBITDA), up from 2.1 years a year ago.
META Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 48.2 | Neutral |
| Stochastic | 33.7 | Neutral |
META's weekly RSI is 48 (neutral) and its Stochastic is 34 (neutral).
MSGK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 66.2 | Neutral |
| Stochastic | 64.3 | Neutral |
MSGK's weekly RSI is 66 (neutral) and its Stochastic is 64 (neutral).
META PE vs Communication Services Sector
| Metric | META | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 16x | 29% above |
| PE % | 18 | 26 | 8 pts below |
META has the edge over MSGK on valuation relative to its sector.
MSGK PE vs Communication Services Sector
| Metric | MSGK | Sector median | Relative |
|---|---|---|---|
| PE | 1,299x | 16x | 7,775% above |
| PE % | 100 | 26 | 74 pts above |
MSGK has no meaningful PE right now: it lost money over the past year.
META Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $674.9 | 7.6% below |
| 20 week MA | $634.5 | 1.7% below |
| 50 week MA | $630.8 | 1.1% below |
| 100 week MA | $647.8 | 3.7% below |
| 200 week MA | $517.5 | 21% above |
META has fallen below most of its moving averages, though it's still 21% above its 200-week average.
MSGK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $305.3 | 3.1% above |
| 20 week MA | $300.6 | 4.8% above |
| 50 week MA | $262.3 | 20% above |
| 100 week MA | $208.7 | 51% above |
| 200 week MA | $176.3 | 79% above |
MSGK has the edge over META on trend strength, trading above more of its moving averages.
META Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $208.1 | $267.4 | +28% |
| 2021 | $267.4 | $335.2 | +25% |
| 2022 | $335.2 | $118.0 | -65% |
| 2023 | $118.0 | $354.0 | +200% |
| 2024 | $354.0 | $599.8 | +69% |
| 2025 | $599.8 | $663.3 | +11% |
| 2026 YTD | $663.3 | $623.6 | -6% |
META's yearly returns have swung widely, from +200% in 2023 to −65% in 2022. It's down 6% so far in 2026.
MSGK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $110.7 | $133.5 | +21% |
| 2021 | $133.5 | $131.1 | -1.8% |
| 2022 | $131.1 | $136.7 | +4.3% |
| 2023 | $136.7 | $136.9 | +0.2% |
| 2024 | $136.9 | $166.5 | +22% |
| 2025 | $166.5 | $195.9 | +18% |
| 2026 YTD | $195.9 | $314.9 | +61% |
MSGK has the edge over META on returns for 2026, with the stronger performance.